ArticleInternational journal of oncology2015

The novel desmopressin analogue [V4Q5]dDAVP inhibits angiogenesis, tumour growth and metastases in vasopressin type 2 receptor-expressing breast cancer models.

Juan Garona et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.